Tekla Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $40.3K | Hold |
5,143
| – | – | ﹤0.01% | 163 |
|
|
2023
Q1 | $37.4K | Sell |
5,143
-1
| -0% | -$7 | ﹤0.01% | 174 |
|
|
2022
Q4 | $17.1K | Hold |
5,144
| – | – | ﹤0.01% | 169 |
|
|
2022
Q3 | $25K | Hold |
5,144
| – | – | ﹤0.01% | 165 |
|
|
2022
Q2 | $39K | Hold |
5,144
| – | – | ﹤0.01% | 174 |
|
|
2022
Q1 | $82K | Hold |
5,144
| – | – | ﹤0.01% | 171 |
|
|
2021
Q4 | $95K | Sell |
5,144
-8,639
| -63% | -$160K | ﹤0.01% | 167 |
|
|
2021
Q3 | $422K | Hold |
13,783
| – | – | 0.01% | 164 |
|
|
2021
Q2 | $757K | Hold |
13,783
| – | – | 0.02% | 176 |
|
|
2021
Q1 | $815K | Hold |
13,783
| – | – | 0.03% | 181 |
|
|
2020
Q4 | $517K | Hold |
13,783
| – | – | 0.02% | 190 |
|
|
2020
Q3 | $744K | Buy |
13,783
+1,159
| +9% | +$62.6K | 0.03% | 187 |
|
|
2020
Q2 | $3.18M | Buy |
+12,624
| New | +$3.18M | 0.12% | 136 |
|